Basic Arimidex Information

• INN (International Nonproprietary Name): Anastrozole
• Brand name(s) available in Australia: Arimidex; anastrozole generic brands may also be supplied
• ATC code: L02BG03
• Forms & dosages: Oral tablet, usually 1 mg once daily
• Manufacturers in Australia: AstraZeneca is the originator company; generic manufacturers may vary by supply
• Registration status in Australia: Prescription only medicine
• OTC / Rx classification: Rx only

Main approved use: Arimidex is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, and it is also used as first-line therapy for locally advanced or metastatic breast cancer in appropriate postmenopausal patients.

Forms & dosages: The commercially established form for Arimidex is the oral tablet, usually 1 mg once daily; the available evidence does not support any cream, injection, vial, or higher-strength Arimidex presentation.

Brand and market naming: In pharmacies and oncology settings, the product is commonly referenced as Arimidex or anastrozole; many markets dispense the generic anastrozole under multiple local manufacturer brands, while Arimidex remains the reference brand name.

SEO-friendly product summary: Arimidex 1 mg tablets (anastrozole) is a prescription-only aromatase inhibitor used in hormone-receptor-positive breast cancer, especially in postmenopausal women, and is supplied as an oral tablet rather than an injectable or topical form.

Recent Evidence And Treatment Trends

Key Trial Readouts And Follow-Up Data

FALCON Final Overall Survival Update

What’s actually changed for Arimidex in the last few years?

Mostly, the answer is that the medicine has stayed clinically important, while the evidence base has become more focused on long-term outcomes, safety, and sequencing rather than new indications.

The phase III FALCON trial produced a final overall survival report in 2024, extending the evidence base for first-line endocrine therapy with anastrozole in advanced breast cancer.

That matters because it reinforces Arimidex as a durable endocrine option rather than a drug being pushed aside by newer therapies.

2025 Observational Data On Stroke And Mortality

There was also 2025 real-world evidence suggesting that longer aromatase inhibitor exposure in selected postmenopausal women with early-stage hormone receptor-positive breast cancer was associated with lower stroke risk and lower all-cause and cardiovascular mortality.

That doesn’t mean everyone should stay on treatment longer without review, but it does support the idea that longer exposure can be reasonable in the right patient.

What The Latest Evidence Means In Practice

For Australian practice, the takeaway is pretty straightforward.

Arimidex remains a core endocrine treatment for postmenopausal women with hormone receptor-positive breast cancer, and the current focus is on monitoring rather than moving away from anastrozole.

That means bone health, cardiovascular risk, symptoms, and adherence still need regular attention through oncology, GP, and pharmacy care.

If a patient asks whether the “new research” means Arimidex is outdated, the short answer is no.

The newer data mainly strengthen confidence in ongoing endocrine therapy, especially for patients who are tolerating treatment and gaining recurrence-prevention benefit.

What Arimidex Is And How It Works

Plain-English Mechanism

Lowering Oestrogen After Menopause

Why does this tablet matter so much in breast cancer care?

Many breast cancers are driven by oestrogen, and after menopause the body still makes small amounts of oestrogen in peripheral tissue through the aromatase enzyme.

Arimidex blocks that enzyme, so less oestrogen is made available to feed hormone-sensitive breast cancer cells.

In simple terms, it helps “starve” the cancer of a growth signal.

Scientific Mechanism

Competitive, Reversible Aromatase Inhibition

Anastrozole is a competitive, reversible, non-steroidal aromatase inhibitor that selectively inhibits CYP19A1.

At the standard 1 mg daily dose, plasma estradiol levels are reduced substantially in postmenopausal women.

The medicine has minimal effect on adrenal corticosteroid or aldosterone synthesis, so routine steroid replacement is not needed.

Arimidex is taken as a 1 mg oral prescription medicine, with or without food, which makes day-to-day use simpler for many patients.

Approved Uses And Who It Is For

TGA-Aligned Use In Australia

Adjuvant Treatment After Surgery

In Australian practice, Arimidex is mainly used for postmenopausal women with hormone receptor-positive early breast cancer after surgery, with or without chemotherapy or radiotherapy.

It is commonly used for about 5 years in adjuvant care, although some higher-risk patients may continue longer under specialist guidance.

Locally Advanced Or Metastatic Disease

Arimidex is also used as first-line therapy in locally advanced or metastatic hormone-sensitive breast cancer, and it can be used after tamoxifen failure.

That is where the FALCON trial remains especially relevant, because it supports the place of anastrozole in first-line endocrine treatment.

Who Should And Should Not Use It

This medicine is not for premenopausal women, pregnancy, or breastfeeding.

It is prescription-only and is usually managed through oncology or breast cancer specialists in Australia.

In practical terms, if someone is still menstruating or could become pregnant, Arimidex is generally not the right treatment.

Dosage, Timing And Administration

Standard Dose

1 Mg Orally Once Daily

The usual Arimidex dosage is 1 mg once daily.

It is best taken at about the same time every day so it becomes part of a routine.

The tablet should be swallowed whole with water and not crushed or split unless a clinician specifically advises otherwise.

How To Take It Correctly

With Or Without Food

There are no major food restrictions, so it can be taken with or without meals.

Missed Dose Advice

If a dose is missed, it should be taken as soon as remembered.

If the next dose is almost due, skip the missed dose and return to the normal schedule.

Doubling up to “catch up” is not recommended.

In adjuvant care, treatment commonly continues for around 5 years, and in metastatic disease it continues until progression or unacceptable toxicity.

Safety, Contraindications And Monitoring

Absolute Contraindications

Hypersensitivity, Pregnancy, Breastfeeding

The main absolute contraindications are hypersensitivity to anastrozole or excipients, pregnancy, and breastfeeding.

Arimidex should not be used in premenopausal women unless a specialist has clearly assessed menopause biochemically and decided otherwise.

Main Safety Concerns

Bone Loss And Fracture Risk

The biggest long-term issue is bone mineral density loss.

Because oestrogen is suppressed, bone turnover can increase, and fracture risk can rise over time.

That is why baseline and follow-up bone health checks matter so much.

Cardiovascular And Lipid Effects

Hot flushes, joint pain, fatigue, headache, nausea, insomnia, mood changes, and rash are commonly reported.

Cardiovascular risk factors and lipid changes also deserve attention, especially in people with existing heart disease or hyperlipidaemia.

Severe liver disease and severe renal impairment need careful specialist assessment before treatment starts.

In Australian practice, this often becomes a shared-care issue between oncology, the GP, and the pharmacist.

Interactions And Lifestyle Considerations

Food And Alcohol

No Major Food Restrictions

Arimidex can be taken with or without food, so meal timing usually does not matter.

Alcohol does not have a well-documented direct interaction with anastrozole, but moderation is sensible, especially if there are liver concerns or general wellbeing issues.

Drugs And Supplements To Flag

DHEA And Hormone Products

Hormone-boosting products and DHEA supplements may reduce effectiveness and should be discussed with the oncology team.

Herbal Menopause Supplements

Any supplement marketed for “hormone balance” or “menopause support” should be mentioned to the pharmacist or oncologist before use.

That includes over-the-counter hormones, phytoestrogen products, and anything that could alter oestrogen signalling.

Patient Experience And Real-World Views

What Patients Report

Benefit Is Often Preventive, Not Felt Day To Day

Many patients say the hardest part is that Arimidex does not produce a noticeable “feel better” effect.

The benefit is preventive, which makes it easier to focus on aches, hot flushes, or fatigue than on the invisible reduction in recurrence risk.

Common Satisfaction Patterns

Mixed Tolerance, Strong Recurrence-Prevention Value

Real-world reviews suggest satisfaction is mixed.

Many people value the peace of mind that comes with recurrence prevention, but side effects can affect quality of life.

Common themes include joint stiffness, hot flushes, fatigue, mood changes, vaginal dryness, and sexual side effects.

Some patients stay on it for years with little trouble, while others discuss switching because pain or insomnia becomes persistent.

That is where pharmacists often help most, by normalising the symptom pattern and encouraging early review rather than silent stopping.

Australian Access, Supply, And Costs

Availability In Australia

Community Pharmacy And Hospital Supply

Arimidex and generic anastrozole are prescription medicines in Australia and may be dispensed through community pharmacy or hospital supply, depending on the patient’s treatment pathway.

They are commonly handled through oncology services, breast clinics, and local pharmacies.

In some cases, our online pharmacy can assist with convenient access and discreet delivery to Australia within 5 to 14 days, but prescription requirements still need to be followed.

Urban patients usually have more choice, while rural patients may rely more on local stock, mail order, or pharmacist coordination.

PBS Versus Private Cost Realities

Why Generics Are Common

The PBS subsidy can materially reduce out-of-pocket cost for eligible patients.

Price sensitivity is high, so generic anastrozole is often preferred where clinically appropriate.

That said, the product name on the box can vary by brand, even though the active ingredient is the same.

Alternatives And Comparative Choice

Main Aromatase Inhibitor Alternatives

Letrozole (Femara)

Letrozole is another non-steroidal aromatase inhibitor used in the same treatment setting.

Some clinicians choose it when they want a different non-steroidal AI profile.

Exemestane (Aromasin)

Exemestane is a steroidal aromatase inhibitor and is often tried when a patient struggles with side effects on anastrozole or letrozole.

It is frequently used after tamoxifen or after intolerance to another AI.

How Clinicians Compare Options

Efficacy, Tolerability, Sequencing

Choice usually depends on oncology history, bone risk, symptom burden, affordability, and access.

Arimidex remains a standard first-line AI, letrozole may be favoured when stronger estrogen suppression is desired, and exemestane is often used when side effects drive switching.

Head-to-head evidence suggests broadly similar effectiveness among the main aromatase inhibitors for many postmenopausal patients.

Bone Health, Fractures And Prevention Strategies

Why Bone Health Matters

Oestrogen Suppression And Bone Turnover

Why do pharmacists keep talking about bones with Arimidex?

Because low oestrogen can accelerate bone loss.

That makes osteoporosis and fracture prevention a major part of long-term care.

Prevention And Monitoring

BMD Scans, Calcium, Vitamin D, Exercise

Baseline bone mineral density assessment is important, with repeat monitoring based on risk.

Calcium, vitamin D, weight-bearing exercise, and sometimes specialist osteoporosis treatment may be needed.

This is one of the clearest shared-care issues in Australia, because oncology, general practice, and pharmacy all play a part.

If joint pain is limiting activity, patients should not just “push through” without advice, because reduced movement can make bone and muscle problems worse.

Regulatory Status And Product Identity

TGA And International Classification

Brand Versus Generic Naming

Arimidex is the brand name, while anastrozole is the INN.

The ATC code is L02BG03, which places it in endocrine therapy and aromatase inhibitors.

Product Specifics

1 Mg Oral Tablet, Rx Only

The product is an oral 1 mg tablet and is prescription only.

Australian listings may use either the brand or generic name depending on supply and pharmacy preference.

That means a patient may see different pack names, but the active ingredient remains the same.

Prescribing And Pharmacist Counselling In Australia

What Pharmacists Usually Explain

Adherence, Timing And Side-Effect Reporting

Pharmacists usually reinforce daily adherence, missed-dose rules, and the importance of side-effect tracking.

Patients should raise new joint pain, hot flushes, vaginal dryness, mood change, or sleep problems early rather than waiting months.

Because the benefit is long-term and invisible day to day, adherence support matters a lot.

Shared-Care Practical Advice

When To Escalate To The GP Or Oncologist

Any severe rash, significant swelling, chest pain, shortness of breath, or major mood change should prompt medical review.

Persistent bone pain, worsening joint stiffness, or repeated falls also deserve prompt assessment.

For many patients, a quick pharmacy conversation can be the difference between stopping early and staying on treatment safely.

Storage, Transport, And Everyday Handling

Home Storage

Keep In Original Pack, Below Heat And Moisture

Store tablets in the original pack, away from heat and moisture.

Australian summer heat makes car storage and bathroom cupboards poor choices.

Travel And Rural Logistics

Avoid Car Heat And Bathroom Storage

No cold-chain is required, but sensible storage still matters.

For travel, keep the medicine in hand luggage rather than a hot boot or glove box.

Frequently Asked Questions

Common Patient Questions

What It Treats, How Long To Use It, Side Effects

Arimidex is not chemotherapy.

It is endocrine therapy that lowers oestrogen to help prevent recurrence or slow hormone-sensitive breast cancer growth.

Many patients use it for about 5 years in early breast cancer, though some need longer treatment.

Common concerns include hot flushes, joint pain, vaginal dryness, weight changes, and libido changes.

Alcohol, Sex Life, And Weight Concerns

Alcohol is usually about moderation and wellbeing rather than a direct interaction.

Sexual side effects and vaginal dryness are common enough that they should be discussed openly, because there are practical ways to help.

Weight gain is not universal, but activity, diet, and strength training can help.

Patients also often want to know about access and price, and that is where pharmacy support and PBS information become important.

Delivery Across Australia

Summary And Key Takeaways

Arimidex, or anastrozole, remains a core postmenopausal breast cancer hormone therapy in Australia.

It is a 1 mg oral prescription medicine taken once daily, usually for years rather than weeks, so adherence matters.

The main issues to watch are bone loss, joint pain, hot flushes, mood or sleep changes, and cardiovascular risk factors.

For many women, the benefit is preventive rather than something they can feel day to day, which is why good pharmacist counselling makes such a difference.

When treatment access, affordability, or supply becomes stressful, a pharmacist can help explain brand options, generic substitution, PBS considerations, and practical ways to stay on therapy safely.